| PERIOD ENDING | 31-Dec-08 |
| Total Revenue |
-
|
| Cost of Revenue |
-
|
|
| Gross Profit |
-
|
|
| Operating Expenses |
| Research Development | 53 |
| Selling General and Administrative | 106 |
| Non Recurring |
-
|
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | (160) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net | 7 |
| Earnings Before Interest And Taxes | (152) |
| Interest Expense |
-
|
| Income Before Tax | (152) |
| Income Tax Expense |
-
|
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | (152) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | (152) |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares | ($152) |
0.67% Nasdaq 
Income Statement
